{
    "id": "3df45803-1670-4da6-afb6-66bc57e16635",
    "indications": {
        "text": "crexont indicated treatment parkinson 's disease , post-encephalitic parkinsonism , parkinsonism may follow carbon monoxide intoxication manganese intoxication adults .",
        "doid_entities": [
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            },
            {
                "text": "parkinsonism (DOID:0080855)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0080855"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "levodopa-na\u00efve patients : starting dose 35 mg carbidopa / 140 mg levodopa taken orally twice daily first 3 days ; fourth day treatment , may increased gradually needed . ( 2.1 ) patients converting immediate-release carbidopa/levodopa : table 1 instructions ; dosages substitutable 1:1 basis . ( 2.2 ) maximum recommended daily crexont 525 mg carbidopa / 2100 mg levodopa . ( 2.1 , 2.2 ) crexont may taken without food ; chew , divide , crush . ( 2.4 , 12.3 ) crexont taken alcohol . ( 2.4 , 12.3 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "adverseReactions": "crexont contraindicated patients currently taking nonselective monoamine oxidase ( mao ) inhibitor recently ( within 2 weeks ) taken nonselective mao inhibitor . hypertension occur drugs used concurrently [ ( 7.1 ) ] .",
    "ingredients": [
        {
            "name": "CARBIDOPA",
            "code": "MNX7R8C5VO",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3395"
        },
        {
            "name": "LEVODOPA",
            "code": "46627O600J",
            "drugbank_id": "https://go.drugbank.com/drugs/DB01235"
        },
        {
            "name": "CELLULOSE ACETATE",
            "code": "3J2P07GVB6",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_145232"
        },
        {
            "name": "COPOVIDONE K25-31",
            "code": "D9C330MD8B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_78913"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER",
            "code": "905HNO1SIH",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_25218"
        },
        {
            "name": "METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)",
            "code": "74G4R6TH13",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_25219"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_29864"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POVIDONE",
            "code": "FZ989GH94E",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11061"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "TRIETHYL CITRATE",
            "code": "8Z96QXD6UM",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_168426"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16134"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "BUTYL ALCOHOL",
            "code": "8PJ61P6TS3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FD&C RED NO. 3",
            "code": "PN2ZH5LOQY"
        }
    ],
    "organization": "Amneal Pharmaceuticals LLC",
    "name": "CREXONT",
    "effectiveTime": "20250212",
    "indications_original": "CREXONT is indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication in adults.",
    "contraindications_original": "Levodopa-na\u00efve patients: Starting dose is 35 mg carbidopa / 140 mg levodopa taken orally twice daily for the first 3 days; on the fourth day of treatment, dosage may be increased gradually as needed. ( 2.1 ) Patients converting from immediate-release carbidopa/levodopa: See Table 1 for instructions; dosages are not substitutable on a 1:1 basis. ( 2.2 ) The maximum recommended daily dosage of CREXONT is 525 mg carbidopa / 2100 mg levodopa. ( 2.1 , 2.2 ) CREXONT may be taken with or without food; do not chew, divide, or crush. ( 2.4 , 12.3 ) CREXONT should not be taken with alcohol. ( 2.4 , 12.3 )",
    "adverseReactions_original": "CREXONT is contraindicated in patients currently taking a nonselective monoamine oxidase (MAO) inhibitor or have recently (within 2\u00a0weeks) taken a nonselective MAO inhibitor. Hypertension can occur if these drugs are used concurrently [see Drug Interactions (7.1)].",
    "drug": [
        {
            "name": "CREXONT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3395"
        }
    ]
}